Table 5.
Baseline characteristics of 117 patients with PAs-induced HSOS at the time of diagnosis
| Variables | Survival Group | Death Group | P Value* |
|---|---|---|---|
| Number of patients | 44 | 28 | |
| Age, years | 59.00 (47.25–63.00) | 61.00 (51.25–65.50) | 0.60 |
| Male Sex; n (%) | 31.00 (70.50%) | 20.00 (71.40%) | 0.42 |
| Erythrocytes, 1012/L | 4.58 (4.11–4.86) | 4.44 (4.07–4.99) | 0.88 |
| Hemoglobin, g/L | 140.00 (128.25–149.75) | 139.00 (120.00–154.00) | 0.84 |
| Leukocyte, 109/L | 5.98 (4.59–7.43) | 7.51 (5.30–8.73) | 0.44 |
| Platelet, 109/L | 110.00 (79.00–168.50) | 101.00 (73.00–137.00) | 0.30 |
| PT, S | 16.40 (15.20–18.70) | 17.00 (16.20–18.70) | 0.53 |
| INR | 1.35 (1.23–1.58) | 1.41 (1.29–1.60) | 0.48 |
| ALT, U/L | 68.00 (41.00–147.00) | 82.00 (39.00–203.00) | 0.35 |
| AST, U/L | 88.00 (59.00–166.00) | 108.00 (63.00–197.00) | 0.40 |
| Total bilirubin, μmol/L | 37.25 (21.80–69.98) | 39.15 (26.03–122.75) | 0.07 |
| ALB, g/l | 32.60 (28.20–34.95) | 29.85 (27.75–32.18) | 0.44 |
| Urea, mmol/L | 6.10 (4.12–7.70) | 5.83 (4.26–8.77) | 0.34 |
| Creatinine, μmol/L | 77.50 (64.35–87.32) | 81.95 (66.42–97.40) | 0.30 |
Note: Continuous variables are presented as median (25th–75th percentiles), and categorical variables are presented as count (percentage); * The p-values refer to T-test or chi-square test between patients with survival group and death group